ACTRN12618001351202
Not yet recruiting
未知
A prospective case series evaluating neo-adjuvant use of Vismodegib in patients with periocular basal cell carcinoma to evaluate reduction in clinical and surgical tumour margins
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Basal cell carcinoma
- Sponsor
- Royal Adelaide Hospital
- Enrollment
- 20
- Status
- Not yet recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Role of chemotherapy in high grade urinary bladder tumourHealth Condition 1: null- CARCINOMA BLADDERCTRI/2016/09/007241KING GEORGE MEDICAL UNIVERSITY25
Not yet recruiting
Phase 2
A Study to assess prognostic score in rectal cancer.CTRI/2020/01/022968Kastruba Medical College
Completed
Phase 2
Prospective feasible study to evaluate neoadjuvant chemoradiotherapy for locally advanced rectal Cancer (Neoadjuvant-synchronus TS1+RT)rectal cancerJPRN-UMIN000003396Oita University faculty of medicine, Department of Surgery I35
Recruiting
Phase 2
The Efficacy and Feasibility Study of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer (Est-Neo)Rectal CancerJPRN-UMIN000005654Gastro-intestinal Sugery Division, Kyoto University Hospital55
Active, not recruiting
Phase 1
Phase II single-arm study evaluating abiraterone acetate (plus prednisolone) and Gonadotropin-Releasing Hormone (GnRH) agonist prior to receiving radical radiotherapy in high risk localised prostate carcinoma patientsHigh-risk prostate cancerMedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-001128-31-IECancer Trials Ireland36